These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38572311)
1. A systematic review and meta-analysis of the diagnosis and surgical management of carcinoid heart disease. Namkoong J; Andraweera PH; Pathirana M; Munawar D; Downie M; Edwards S; Averbuj P; Arstall MA Front Cardiovasc Med; 2024; 11():1353612. PubMed ID: 38572311 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. What do we know about carcinoid heart disease in the present era? Pęczkowska M; Konsek-Komorowska SJ; Kolasińska-Ćwikła AD; Konka M; Michałowska I; Ćwikła JB Kardiol Pol; 2022; 80(10):990-1001. PubMed ID: 36136036 [TBL] [Abstract][Full Text] [Related]
4. Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review. Buchanan-Hughes A; Pashley A; Feuilly M; Marteau F; Pritchard DM; Singh S Neuroendocrinology; 2021; 111(1-2):1-15. PubMed ID: 32097914 [TBL] [Abstract][Full Text] [Related]
5. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours. Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452 [TBL] [Abstract][Full Text] [Related]
6. Carcinoid heart disease in patients with midgut neuroendocrine tumours. Delhomme C; Walter T; Arangalage D; Suc G; Hentic O; Cachier A; Alkhoder S; François L; Lombard-Bohas C; Iung B; Ruszniewski P; de Mestier L J Neuroendocrinol; 2023 Apr; 35(4):e13262. PubMed ID: 37005217 [TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary team management of carcinoid heart disease. Steeds R; Sagar V; Shetty S; Oelofse T; Singh H; Ahmad R; Bradley E; Moore R; Vickrage S; Smith S; Yim I; Elhassan YS; Venkataraman H; Ayuk J; Rooney S; Shah T Endocr Connect; 2019 Dec; 8(12):R184-R199. PubMed ID: 31751305 [TBL] [Abstract][Full Text] [Related]
8. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease. Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343 [TBL] [Abstract][Full Text] [Related]
9. Update in carcinoid heart disease - the heart of the matter. Oleinikov K; Korach A; Planer D; Gilon D; Grozinsky-Glasberg S Rev Endocr Metab Disord; 2021 Sep; 22(3):553-561. PubMed ID: 33443717 [TBL] [Abstract][Full Text] [Related]
10. Four decades of experience with carcinoid heart disease: An analysis of 84 patients. Levy S; Korse CE; de Groot ACA; Meijer RCA; Tesselaar MET; Valk GD J Neuroendocrinol; 2022 Oct; 34(10):e13199. PubMed ID: 36256859 [TBL] [Abstract][Full Text] [Related]
12. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease. Zuetenhorst JM; Korse CM; Bonfrer JM; Bakker RH; Taal BG Br J Cancer; 2004 Jun; 90(11):2073-9. PubMed ID: 15150565 [TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates. Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359 [TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
16. Exercise-based cardiac rehabilitation for coronary heart disease. Anderson L; Thompson DR; Oldridge N; Zwisler AD; Rees K; Martin N; Taylor RS Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD001800. PubMed ID: 26730878 [TBL] [Abstract][Full Text] [Related]
17. Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management. Jin C; Sharma AN; Thevakumar B; Majid M; Al Chalaby S; Takahashi N; Tanious A; Arockiam AD; Beri N; Amsterdam EA Cardiology; 2021; 146(1):65-73. PubMed ID: 33070143 [TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with carcinoid heart disease after valvular surgery. Manoly I; McAnelly SL; Sriskandarajah S; McLaughlin KE Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):302-5. PubMed ID: 24812331 [TBL] [Abstract][Full Text] [Related]
19. Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours. Suc G; Cachier A; Hentic O; Bazire B; Sannier A; Delhomme C; Nataf P; Laschet J; Deschamps L; Garbarz E; Ou P; Caligiuri G; Iung B; Ruszniewski P; de Mestier L; Arangalage D Heart; 2023 Dec; 110(2):132-139. PubMed ID: 37463732 [TBL] [Abstract][Full Text] [Related]
20. Morphologic features of carcinoid heart disease as assessed by three-dimensional transesophageal echocardiography. Nalawadi SS; Siegel RJ; Wolin E; Yu R; Trento A; Shiota T; Tolstrup K; Luthringer D; Gurudevan S Echocardiography; 2010 Oct; 27(9):1098-105. PubMed ID: 21039812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]